Menten AI
Private Company
Building the world's most advanced generative AI platform for peptide therapeutics design.
Biotechnology Research
San Francisco, CA
2-10 employees
Founded Aug 2018
About Menten AI
Menten AI is dedicated to creating life-changing medicines by unlocking the potential of peptide macrocycles. The company provides a generative AI platform (MAUD 1.0) and computational services to design and optimize novel peptide therapeutics. It partners with pharmaceutical companies, biotech firms, and research institutions to accelerate their drug discovery and development processes.
Company Classification
Customer Types
B2BB2D
Business Models
ProductsServicesSubscription
Product & Service Types
Generative AI Platform for Drug DiscoveryComputational Peptide Design Services
Funding
Total Funding
$4.00M
No. of Funding Rounds
3
Customers
| Customer | Success Story | Source |
|---|---|---|
| Leveraged Menten AI’s generative AI platform to accelerate the design and optimization of peptide macrocycles. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos